Expired activity
Please go to the PowerPak
homepage and select a course.
Role of Specialty Pharmacists in Optimizing Management of Patients with PAH
This activity is supported by educational grant funding from Actelion Pharmaceuticals, US.
Release date:
December 22, 2016
Expiration date:
March 8, 2018
Estimated time to complete activity
1.5 hours
TARGET AUDIENCE
This activity is intended for specialty pharmacists engaged in the care of patients with PAH.
EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:
- Identify the signs, symptoms, and risk factors for PAH
- Recognize the classification system for PH and its implications for treatment
- Describe the classes of pharmacotherapeutic agents used in PAH, their indications and methods of administration
- Discuss the role of specialty pharmacists in the care of patients with PAH
FACULTY
James C. Coons, PharmD, BCPS-AQ Cardiology
Associate Professor, University of Pittsburgh School of Pharmacy
Clinical Pharmacist, Cardiology, UPMC-Presbyterian Hospital
PGY2 Cardiology Residency Program Director
Pittsburgh, PA
Rebekah Hanson Anguiano, PharmD
Clinical Assistant Professor, Pharmacy Practice
Clinical Pharmacist, Ambulatory Pharmacy Services
Chicago, IL
Continuing Pharmacy Education
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - 0809-9999-16-541-H01-P)
Type of Activity: Knowledge
Media: Internet
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Faculty
James C. Coons, PharmD, BCPS
Dr. James C. Coons has nothing to disclose.
Rebekah Hanson Anguiano, PharmD
Consulting fees from United Therapeutics
Planners and Managers
The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose. Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
HOW TO EARN CREDIT
During the period December 22, 2016 through March 8, 2018, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the pretest, posttest and the evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on Submit Posttest at the bottom of the page. Your posttest will automatically be graded. If you successfully complete the posttest (score of 70% or higher), your Statement of Participation will be made available immediately. Click on View Statement of Participation and print the statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the posttest. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.
Disclosure of Unlabeled Use and Disclaimer
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
REQUIRED COMPUTER HARDWARE/SOFTWARE
Please ensure the computer system you plan to use meets the following minimum requirements:
- Operating System: Windows 98 or higher & Macintosh 2.2 or higher
- Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
- Peripherals: Computer speakers or headphones
- Monitor Screen Resolution: 320 x 480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5
